|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 23, 2016 ) Endometriosis is a common health condition in women where the endometrial tissue, which is found in the lining of the uterus, appears and grows outside the uterine cavity. The endometrial tissue is shed from the body during menstruation.
The tissue growing outside the uterine cavity is called endometrial implants. Endometriosis can also occur in the fallopian tubes, ovaries, pelvic cavity, vagina, cervix, and bladder. In rare cases, it has been reported in other parts of the body such as the lungs, brain, and skin. These implants are usually benign in nature. Women of reproductive age are often affected by this condition.
Endometriosis often occurs due to retrograde menstruation, where the menstrual blood flows back into the pelvic cavity instead of leaving the body. This then adheres to the surface of the bladder, ovaries, or rectum and continues to grow or thicken over the course of each menstrual cycle.
Publisher's analysts forecast the global endometriosis market to grow at a CAGR of 2.05% during the period 2016-2020.
For more information about this report http://www.reportsweb.com/global-endometriosis-drugs-market-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the global endometriosis market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of approved and off-label branded and generic drugs used for the treatment and prevention of endometriosis and related pain. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Endometriosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- AbbVie
- AstraZeneca
- Bayer HealthCare
- Pfizer
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001309806/sample .
Other prominent vendors
- Addex Therapeutics
- Astellas Pharma
- Debiopharm
- ElexoPharm
- Endoceutics
- Euroscreen
- Forendo Pharma
- Isifer
- Kissei Pharmaceutical
- Neurocrine Biosciences
- Nippon Shinyaku
- ObsEva
- Orphagen Pharmaceuticals
- Philogen
- PregLem
- Repros Therapeutics
- Roivant Sciences
- SK Chemicals
- Speciality European Pharma
- SYNG Pharmaceuticals
- Takeda
- United Pharmaceuticals
- ValiPharma
Market driver
- Increased adoption of OCPs
- For a full, detailed list, view our report
Market challenge
- Surgeries as primary treatment option
- For a full, detailed list, view our report
Market trend
- Increased focus on intrauterine devices (IUDs)
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001309806/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
